Adaptive Biotechnologies (STU:1HM) Other Stockholders Equity : €-0.0 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adaptive Biotechnologies Other Stockholders Equity?

Adaptive Biotechnologies's Other Stockholders Equity for the quarter that ended in Sep. 2024 was €-0.0 Mil.

Adaptive Biotechnologies's quarterly Other Stockholders Equity declined from Mar. 2024 (€0.0 Mil) to Jun. 2024 (€0.0 Mil) and declined from Jun. 2024 (€0.0 Mil) to Sep. 2024 (€-0.0 Mil).

Adaptive Biotechnologies's annual Other Stockholders Equity increased from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€0.0 Mil) but then declined from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€0.0 Mil).

Adaptive Biotechnologies Other Stockholders Equity Historical Data

The historical data trend for Adaptive Biotechnologies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adaptive Biotechnologies Other Stockholders Equity Chart

Adaptive Biotechnologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

Adaptive Biotechnologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

Adaptive Biotechnologies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Adaptive Biotechnologies Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Adaptive Biotechnologies's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Adaptive Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adaptive Biotechnologies Corp (STU:1HM) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ADPT:USA 1HM:Germany

Address

1165 Eastlake Avenue East, Seattle, WA, USA, 98109

Website

https://www.adaptivebiotech.com

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Adaptive Biotechnologies Headlines

No Headlines